Back to Search
Start Over
Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance
- Source :
- Leukemia Research. 16:673-680
- Publication Year :
- 1992
- Publisher :
- Elsevier BV, 1992.
-
Abstract
- To help understanding host-tumor relationships in acute myelogenous leukemia (AML) and better define indications for interleukin 2 (IL-2) therapy in this disease, we studied the relationship between the susceptibility of leukemic cells of 44 AML patients to lysis by autologous (26 cases) and/or allogeneic (41 cases) lymphokine-activated killer (LAK) cells and characteristics of the leukemia. Lymphocytes were activated in the presence of 1000 u/ml recombinant IL-2 for 5 days. Lysis of AML cells was studied by 51 Cr release. Average lysis of AML cells by autologous LAK cells was 9 ± 13% and by allogeneic LAK cells 10 ± 9% with a significant correlation between lyses by both effectors ( p = 0.01). Autologous ( p = 0.005) and allogeneic ( p = 0.004) lyses were higher in patients with initial infection. Allogeneic lysis was correlated with initial WBC count ( p = 0.009), serum lactic-dehydrogenase level ( p = 0.05), and expression of CD13 ( p = 0.01). Autologous lysis was inversely correlated with expression of CD34 ( p = 0.003). Expression of adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) by the leukemic cells did not correlate with their lysis by LAK cells. Susceptibility of leukemic cells to lysis by LAK cells did not correlate with prognosis of the leukemia.
- Subjects :
- Adult
Cytotoxicity, Immunologic
Male
Interleukin 2
Cancer Research
medicine.medical_treatment
Lymphocyte
CD34
Antigens, Differentiation, Myelomonocytic
Antigens, CD34
chemical and pharmacologic phenomena
CD13 Antigens
Leukocyte Count
Myelogenous
Antigens, CD
Antigens, Neoplasm
Tumor Cells, Cultured
medicine
Humans
Killer Cells, Lymphokine-Activated
Aged
Proportional Hazards Models
Membrane Glycoproteins
Lymphokine-activated killer cell
L-Lactate Dehydrogenase
business.industry
Lymphokine
hemic and immune systems
Hematology
Middle Aged
CD58 Antigens
Intercellular Adhesion Molecule-1
Prognosis
medicine.disease
Recombinant Proteins
Leukemia, Myeloid, Acute
Leukemia
Cytokine
medicine.anatomical_structure
Oncology
Antigens, Surface
Multivariate Analysis
Immunology
Interleukin-2
Female
business
Cell Adhesion Molecules
medicine.drug
Subjects
Details
- ISSN :
- 01452126
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Leukemia Research
- Accession number :
- edsair.doi.dedup.....60d67888047972fdf3a65fc0089fb36e